Tennessee Viberzi Lawyer
According to medical professionals, up to 20 percent of the population suffers from some form of irritable bowel syndrome (IBS). And about one-third of IBS patients actually have IBS associated with diarrhea (IBS-D). As the name suggests, the key symptoms of IBS-D include frequent diarrhea and chronic abdominal pain. This is due to the fact IBS renders a patient’s colon more sensitive to stress and bacterial infection.
There are a number of prescription and over-the-counter drugs available to treat IBS-D. One of the more recently approved prescription medications is eluxadoline, which is sold by pharmaceutical giant Allergan under the brand name Viberzi. The U.S. Food and Drug Administration (FDA) first approved Viberzi for use as an IBS-D treatment in May 2015. But the drug has potentially deadly side effects–a fact that was not made public for another two years until after the initial release.
If you or a member of your family have sustained injuries as the result of using Viberzi, you may be entitled to legal compensation. The Tennessee Viberzi lawyers at Fox & Farley can review your situation and assist you in assessing a potential claim against Allergan and other negligent third parties.
Do Not Take Viberzi Unless You Still Have Your Gallbladder
In March 2017, two years after approving Viberzi for sale in the United States, the FDA issued a “Drug Safety Communication” warning patients they should not take the drug for IBS-D if their gallbladder was previously removed. The FDA said that according to an internal review, patients without a gallbladder “have an increased risk of developing serious pancreatitis that could result in hospitalization or death.” For these patients, there are other drugs that can treat IBS-D without the same risks as Viberzi.
Allergan itself admits that pancreatitis “has led to death” in cases where a patient took Viberzi without a gallbladder. Indeed, it is possible to develop pancreatitis after just taking 1 or 2 doses of the drug. But in most cases, Allergan said problems developed “within the first week of treatment.”
Aside from patients lacking a gallbladder, Allergan further advises IBS-D patients not to use Viberzi if they have prior issues with alcohol abuse, severe liver problems, chronic or severe constipation, intestinal obstruction, or show signs of an allergy to the drug.
Contact Fox & Farley Today for an Assessment of Your Viberzi-Related Product Liability Claim
If you took Viberzi, particularly between 2015 and 2017, and developed pancreatitis, you may have a claim for damages. As with any dangerous or defective drug case, you can seek financial compensation to cover your past and future medical expenses, pain and suffering, and loss of income and earning capacity arising from Viberzi-related complications. The experienced Tennessee Viberzi lawyers at Fox & Farley can advise you on what steps to take next.
Fox & Farley serves clients in Tennessee cities such as Knoxville, Clinton, Oak Ridge, Kingston, La Follette, Maryville, Sevierville, Pigeon Forge, Gatlinburg and others throughout Knox County, Anderson County, Roane County, Macon County, Blount County, Campbell County, Claiborne County, Morgan County, Scott County, Sevier County, and Union County.